2017 annual financial data
Iovance Biotherapeutics 2017 Operating margin
Iovance Biotherapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -92,877,000 USD and net income was -92,064,000 USD.
Operating cash flow was -78,709,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -92,877,000 USD
- Net income
- -92,064,000 USD
- Operating cash flow
- -78,709,000 USD